O'Connor KM - Search Results

1

Acute electrophysiologic effects and antiarrhythmic/antifibrillatory activity of intravenous amiodarone in a chronic feline infarction model.

Marinchak RA, O'Connor KM, Friehling TD, Kowey PR. Marinchak RA, et al. J Cardiovasc Pharmacol. 1989 Sep;14(3):389-95. doi: 10.1097/00005344-198909000-00006. J Cardiovasc Pharmacol. 1989. PMID: 2476617

2

Electrophysiologic effects of left ventricular hypertrophy in the intact cat.

Shechter JA, O'Connor KM, Friehling TD, Mark R, Uboh C, Kowey PR. Shechter JA, et al. Am J Hypertens. 1989 Feb;2(2 Pt 1):81-5. doi: 10.1093/ajh/2.2.81. Am J Hypertens. 1989. PMID: 2521793

3

The effect of beta-adrenergic blockade on vulnerability to ventricular fibrillation and inducibility of ventricular arrhythmia in short- and long-term feline infarction models.

Luketich J, Friehling TD, O'Connor KM, Kowey PR. Luketich J, et al. Am Heart J. 1989 Aug;118(2):265-71. doi: 10.1016/0002-8703(89)90184-1. Am Heart J. 1989. PMID: 2750648

4

The effect of thromboxane inhibition on vulnerability to ventricular fibrillation in the acute and chronic feline infarction models.

O'Connor KM, Friehling TD, Kowey PR. O'Connor KM, et al. Am Heart J. 1989 Apr;117(4):848-53. doi: 10.1016/0002-8703(89)90622-4. Am Heart J. 1989. PMID: 2929400

5

The effect of bretylium and clofilium on dispersion of refractoriness and vulnerability to ventricular fibrillation in the ischemic feline heart.

Kowey PR, Friehling TD, O'Connor KM, Wetstein L, Kelliher GJ. Kowey PR, et al. Am Heart J. 1985 Aug;110(2):363-70. doi: 10.1016/0002-8703(85)90157-7. Am Heart J. 1985. PMID: 4025111

6

Arrhythmia inducibility and ventricular vulnerability in a chronic feline infarction model.

Wetstein L, Mark R, Kelliher GJ, Friehling T, O'Connor KM, Kowey PR. Wetstein L, et al. Am Heart J. 1985 Nov;110(5):955-60. doi: 10.1016/0002-8703(85)90191-7. Am Heart J. 1985. PMID: 4061270

7

Influence of site of stimulation on measurement of ventricular vulnerability in the normal and ischemic feline heart.

Kowey PR, Friehling TD, Wetstein L, O'Connor KM, Kelliher GJ. Kowey PR, et al. Am J Cardiol. 1984 Aug 1;54(3):421-3. doi: 10.1016/0002-9149(84)90209-1. Am J Cardiol. 1984. PMID: 6465027

8

Effect of thromboxane synthetase inhibition on vulnerability to ventricular arrhythmia following coronary occlusion.

O'Connor KM, Friehling TD, Kelliher GJ, MacNab MW, Wetstein L, Kowey PR. O'Connor KM, et al. Am Heart J. 1986 Apr;111(4):683-8. doi: 10.1016/0002-8703(86)90099-2. Am Heart J. 1986. PMID: 3953390

9

Dextran-Encapsulated Nanoparticles and Super-Nanoparticle Assemblies: Preparation from Quantum Dots, Fluorescent Polymers, and Magnetic Nanoparticles for Application to Cellular Immunolabeling.

Rees K, Darwish GH, Bernal-Escalante J, O'Connor KM, Cheong IT, Veinot JGC, Algar WR. Rees K, et al. Among authors: o connor km. ACS Appl Mater Interfaces. 2024 Nov 27;16(47):64554-64567. doi: 10.1021/acsami.4c14719. Epub 2024 Nov 15. ACS Appl Mater Interfaces. 2024. PMID: 39546415

10

Treatment of Common Dermatologic Conditions.

Tan N, Vary JC Jr, O'Connor KM. Tan N, et al. Among authors: o connor km. Med Clin North Am. 2024 Sep;108(5):795-827. doi: 10.1016/j.mcna.2024.02.002. Epub 2024 Jun 12. Med Clin North Am. 2024. PMID: 39084835 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters